Dolby Laboratories (NYSE:DLB) CFO Sells $277,448.60 in Stock

Dolby Laboratories (NYSE:DLBGet Free Report) CFO Robert Park sold 4,895 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $56.68, for a total transaction of $277,448.60. Following the completion of the transaction, the chief financial officer owned 81,490 shares in the company, valued at approximately $4,618,853.20. This represents a 5.67% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

Dolby Laboratories Trading Up 0.9%

DLB stock traded up $0.47 during midday trading on Thursday, reaching $54.75. The company had a trading volume of 852,391 shares, compared to its average volume of 779,842. The company has a 50 day moving average of $61.32 and a two-hundred day moving average of $63.85. The company has a market capitalization of $5.18 billion, a P/E ratio of 21.64 and a beta of 0.86. Dolby Laboratories has a 1 year low of $53.45 and a 1 year high of $77.59.

Dolby Laboratories (NYSE:DLBGet Free Report) last posted its quarterly earnings results on Thursday, April 30th. The electronics maker reported $1.37 earnings per share for the quarter, topping analysts’ consensus estimates of $1.31 by $0.06. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. The business had revenue of $395.63 million for the quarter, compared to the consensus estimate of $385.80 million. During the same period in the prior year, the business posted $1.34 earnings per share. Dolby Laboratories’s revenue for the quarter was up 7.0% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. On average, sell-side analysts anticipate that Dolby Laboratories will post 3.22 earnings per share for the current year.

Dolby Laboratories Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th will be given a $0.36 dividend. This represents a $1.44 annualized dividend and a yield of 2.6%. The ex-dividend date of this dividend is Tuesday, May 12th. Dolby Laboratories’s dividend payout ratio is presently 56.92%.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. First Horizon Corp bought a new position in shares of Dolby Laboratories in the 3rd quarter valued at approximately $25,000. Hantz Financial Services Inc. lifted its holdings in Dolby Laboratories by 166.7% in the 3rd quarter. Hantz Financial Services Inc. now owns 352 shares of the electronics maker’s stock worth $25,000 after purchasing an additional 220 shares during the last quarter. Rothschild Investment LLC boosted its position in Dolby Laboratories by 4,046.7% during the third quarter. Rothschild Investment LLC now owns 622 shares of the electronics maker’s stock worth $45,000 after purchasing an additional 607 shares during the period. Fifth Third Bancorp boosted its position in Dolby Laboratories by 34.7% during the fourth quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock worth $48,000 after purchasing an additional 192 shares during the period. Finally, Migdal Insurance & Financial Holdings Ltd. acquired a new position in Dolby Laboratories during the third quarter valued at approximately $50,000. Institutional investors and hedge funds own 58.56% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently commented on DLB. Rosenblatt Securities reissued a “buy” rating and issued a $85.00 price target on shares of Dolby Laboratories in a research note on Friday, January 30th. Barrington Research reaffirmed an “outperform” rating and set a $90.00 price objective on shares of Dolby Laboratories in a research report on Monday, April 27th. Wall Street Zen downgraded shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, January 31st. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Friday, March 27th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $90.75.

Read Our Latest Analysis on DLB

About Dolby Laboratories

(Get Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

Featured Stories

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.